Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:INBS NASDAQ:IRIX NYSE:RVP NASDAQ:ZJYL On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeINBSIntelligent Bio Solutions$2.42-0.2%$3.28$2.29▼$24.90$4.83M4.24498,955 shs13,183 shsIRIXIRIDEX$1.03-1.9%$1.19$0.87▼$1.65$17.92M0.64218,148 shs43,643 shsRVPRetractable Technologies$0.71-2.5%$0.68$0.60▼$1.14$21.14M1.2555,944 shs20,400 shsZJYLJin Medical International$2.37+0.4%$2.32$1.64▼$18.00$18.55M7.5232,245 shs5,340 shs10 Best Stocks to Own in 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Spring 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceINBSIntelligent Bio Solutions+0.41%0.00%-12.00%-65.18%-81.09%IRIXIRIDEX+1.94%+0.96%+7.11%-27.08%-8.70%RVPRetractable Technologies+14.54%+16.06%+6.00%+1.94%-3.72%ZJYLJin Medical International+3.45%+4.35%+29.73%-14.29%-85.00%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeINBSIntelligent Bio Solutions$2.42-0.2%$3.28$2.29▼$24.90$4.83M4.24498,955 shs13,183 shsIRIXIRIDEX$1.03-1.9%$1.19$0.87▼$1.65$17.92M0.64218,148 shs43,643 shsRVPRetractable Technologies$0.71-2.5%$0.68$0.60▼$1.14$21.14M1.2555,944 shs20,400 shsZJYLJin Medical International$2.37+0.4%$2.32$1.64▼$18.00$18.55M7.5232,245 shs5,340 shs10 Best Stocks to Own in 2026Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Spring 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment. Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceINBSIntelligent Bio Solutions+0.41%0.00%-12.00%-65.18%-81.09%IRIXIRIDEX+1.94%+0.96%+7.11%-27.08%-8.70%RVPRetractable Technologies+14.54%+16.06%+6.00%+1.94%-3.72%ZJYLJin Medical International+3.45%+4.35%+29.73%-14.29%-85.00%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceINBSIntelligent Bio Solutions 1.00SellN/AN/AIRIXIRIDEX 2.00Hold$3.00191.26% UpsideRVPRetractable Technologies 0.00N/AN/AN/AZJYLJin Medical International 1.00SellN/AN/ACurrent Analyst Ratings BreakdownLatest INBS, IRIX, RVP, and ZJYL Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/4/2026IRIXIRIDEX Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)4/21/2026INBSIntelligent Bio Solutions Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)4/15/2026ZJYLJin Medical International Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D+)(Data available from 5/6/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookINBSIntelligent Bio Solutions$3.05M1.58N/AN/A$4.07 per share0.59IRIXIRIDEX$52.67M0.34N/AN/A($0.06) per share-17.17RVPRetractable Technologies$38.27M0.55$0.01 per share48.25$3.31 per share0.21ZJYLJin Medical International$20.69M0.90$0.17 per share13.65$3.78 per share0.63Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateINBSIntelligent Bio Solutions-$10.57M-$14.82N/AN/AN/A-315.33%-200.68%-97.31%5/12/2026 (Estimated)IRIXIRIDEX-$4.44M-$0.26N/AN/AN/A-8.42%-1,204.74%-14.39%5/11/2026 (Estimated)RVPRetractable Technologies-$7.01M-$0.42N/AN/AN/A-41.11%-17.15%-9.33%N/AZJYLJin Medical International$1.19MN/AN/AN/AN/AN/AN/AN/AN/ALatest INBS, IRIX, RVP, and ZJYL EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/12/2026N/AINBSIntelligent Bio Solutions$1.40N/AN/AN/A$7.20 millionN/A5/11/2026Q1 2026IRIXIRIDEX-$0.07N/AN/AN/A$11.91 millionN/A3/26/2026Q4 2025IRIXIRIDEX-$0.02-$0.01+$0.01-$0.01$14.74 million$14.72 million2/12/2026Q2 2026INBSIntelligent Bio Solutions$0.40-$2.82-$3.22-$2.82$5.50 million$0.90 millionCompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthINBSIntelligent Bio SolutionsN/AN/AN/AN/AN/AIRIXIRIDEXN/AN/AN/AN/AN/ARVPRetractable TechnologiesN/AN/AN/AN/AN/AZJYLJin Medical InternationalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioINBSIntelligent Bio SolutionsN/A2.372.26IRIXIRIDEXN/A1.911.32RVPRetractable Technologies0.018.575.92ZJYLJin Medical InternationalN/A1.861.65Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipINBSIntelligent Bio Solutions32.97%IRIXIRIDEX20.10%RVPRetractable Technologies7.58%ZJYLJin Medical InternationalN/AInsider OwnershipCompanyInsider OwnershipINBSIntelligent Bio Solutions1.27%IRIXIRIDEX8.60%RVPRetractable Technologies59.50%ZJYLJin Medical InternationalN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableINBSIntelligent Bio Solutions102.00 million1.98 millionNot OptionableIRIXIRIDEX12017.40 million15.90 millionOptionableRVPRetractable Technologies24029.94 million13.47 millionOptionableZJYLJin Medical International2457.83 millionN/ANot OptionableINBS, IRIX, RVP, and ZJYL HeadlinesRecent News About These CompaniesJin Medical Regains Nasdaq Bid-Price Compliance After Reverse Share SplitApril 10, 2026 | theglobeandmail.comJin Medical International Ltd. Has Regained Compliance with Nasdaq's Minimum Bid Price RequirementApril 7, 2026 | prnewswire.comJin Medical International Ltd. Announces 1-for-20 Share Combination as Part of Strategic Nasdaq Compliance InitiativeMarch 11, 2026 | prnewswire.comJin Medical Shareholders Approve Dual-Class Structure and Conditional Reverse SplitsFebruary 7, 2026 | theglobeandmail.comJin Medical CEO Fireside ChatFebruary 5, 2026 | prnewswire.comJin Medical to Host February 1 Fireside Chat as It Revamps Corporate WebsiteJanuary 28, 2026 | tipranks.comJin Medical International Ltd. To Host Management Fireside ChatJanuary 26, 2026 | prnewswire.comJin Medical Sets April Launch for High-Capacity Chuzhou Mobility Device PlantJanuary 22, 2026 | tipranks.comJin Medical Announces the Official Commencement Date of Chuzhou FacilityJanuary 22, 2026 | prnewswire.comJin Medical International Ltd. Management Plans For Fireside ChatJanuary 21, 2026 | finance.yahoo.comJin Medical International Ltd. to Host Fireside Chat on Strategic Priorities and Capital Structure on February 1, 2026January 21, 2026 | quiverquant.comQJin Medical Calls January 30 EGM to Restructure Share Capital and Adopt New Equity PlanJanuary 8, 2026 | tipranks.comJin Medical International (NASDAQ:ZJYL) Trading Down 4.6% – Should You Sell?November 22, 2025 | defenseworld.netDAre Jin Medical International Ltd.'s (NASDAQ:ZJYL) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?October 5, 2025 | uk.finance.yahoo.comJin Medical International (NASDAQ:ZJYL) Will Want To Turn Around Its Return TrendsAugust 25, 2025 | finance.yahoo.comJin Medical International Reports Decline in Revenue and Profit for H1 2025August 20, 2025 | msn.comJin Medical International Ltd News (ZJYL) - Investing.comAugust 20, 2025 | investing.comJin Medical International Ltd. Launches Production at New Intelligent Manufacturing Facility in Anhui, ChinaJuly 15, 2025 | quiverquant.comQJin Medical Launches Production at Plant No. 3, Accelerating Global Delivery from the Chuzhou Manufacturing FacilityJuly 15, 2025 | globenewswire.comJin Medical Faces Nasdaq Listing Compliance ChallengeMay 6, 2025 | tipranks.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeINBS, IRIX, RVP, and ZJYL Company DescriptionsIntelligent Bio Solutions NASDAQ:INBS$2.42 -0.01 (-0.21%) As of 02:20 PM Eastern This is a fair market value price provided by Massive. Learn more.Intelligent Bio Solutions Inc., a medical technology company, developing non-invasive, real-time monitoring, and diagnostic tests for patients and their primary health practitioners. It offers saliva glucose biosensor for diabetes management that measures glucose in saliva. The company also provides intelligent fingerprinting drug screening system, a revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields; and biosensor platform for biochemistry, immunology, tumor markers, hormones, and nucleic acid diagnostic modalities. The company was formerly known as GBS Inc. and changed its name to Intelligent Bio Solutions Inc. in October 2022. The company was incorporated in 2016 and is headquartered in New York, New York. Intelligent Bio Solutions Inc. is a subsidiary of Life Science Biosensor Diagnostics Pty Ltd.IRIDEX NASDAQ:IRIX$1.03 -0.02 (-1.90%) As of 02:20 PM Eastern This is a fair market value price provided by Massive. Learn more.IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.Retractable Technologies NYSE:RVP$0.71 -0.02 (-2.53%) As of 02:18 PM Eastern This is a fair market value price provided by Massive. Learn more.Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and a direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.Jin Medical International NASDAQ:ZJYL$2.37 +0.01 (+0.38%) As of 02:19 PM Eastern This is a fair market value price provided by Massive. Learn more.Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Boarding Passes Now Being Issued for the Ultimate eVTOL Arbitrage Years in the Making, AMD’s Upside Movement Has Just Begun Western Digital: The Storage Behemoth Skyrocketing on AI Demand Old Money, New Tech: Western Union's Crypto Reboot Pinterest Pins a Profit Play To Its Mood Board Just How Big a Problem Could Amazon’s Cash Burn Rate Be? BlackBerry Rewrites Its Own Operating System Grab Holdings Faces Hurdles, But Upside Potential Is Hard to Ignore Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
